The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, S. W.
Right arrow Articles by Sung, Y. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S. W.
Right arrow Articles by Sung, Y. C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2003, 170: 2456-2460.
Copyright © 2003 by The American Association of Immunologists

Inhibition of TCR-Induced CD8 T Cell Death by IL-12: Regulation of Fas Ligand and Cellular FLIP Expression and Caspase Activation by IL-121

Seung Woo Lee2, Yunji Park2, Jae Kwang Yoo, So Young Choi and Young Chul Sung3

National Laboratory of DNA Medicine, Division of Molecular and Life Sciences, Pohang University of Science and Technology, Pohang, Korea


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this study we demonstrate the anti-apoptotic effect of IL-12 and its underlying mechanism in CD8 T cells. The prolonged stimulation of CD8 T cells with anti-CD3 alone caused apoptosis mediated by Fas and the caspase signaling pathway. However, costimulation with IL-12 significantly prevented anti-CD3-induced apoptosis of CD8 T cells. IL-12 decreased the number of Fas ligand-positive CD8 T cells and inhibited the activation of caspase-8 and caspase-3. In addition, IL-12 up-regulated cellular FLIPs but not Bcl-2 family proteins or cellular inhibitor of apoptosis proteins. These data suggest that IL-12 provides survival signals to CD8 T cells by down-regulating Fas ligand and up-regulating cellular FLIPs, followed by inhibiting caspase activation, which implies a role for IL-12 in peripheral responses of CD8 T cells in vivo.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Interleukin-12, a heterodimeric cytokine composed of disulfide-linked p35 and p40, plays a key role in cell-mediated immune responses (1, 2). IL-12 drives the differentiation of naive CD4 T cells into Th1 cells and maturates cytotoxic functions of CTLs and NK cells. In addition, IL-12 was reported to be involved in long-term memory T cell responses in vivo. The coadministration of IL-12 DNA sustains long-term Th1 immune responses for Leishmania major (3), and exogenous IL-12 selectively enhances turnover of memory phenotype CD8 T cells (4). Recently, IL-12 has been shown to inhibit apoptosis of CD4 T cells. IL-12 prevents activation-induced or Fas-mediated apoptosis of human CD4 T cells (5), and the neutralization of endogenous IL-12 promotes Fas-mediated apoptosis of murine CD4 T cells in vivo (6). It was recently reported that IL-12 decreases activation-induced cell death (AICD)4 of human Th cells costimulated with ICAM-1 by altering the processing of caspase-3 and caspase-9 and inhibiting enzyme function of caspase-3 (7). However, the role of IL-12 in CD8 T cell apoptosis has not been addressed. In this study we demonstrate that IL-12 provides survival signals to CD8 T cells and that these anti-apoptotic effects result from the inhibition of caspase-8 and caspase-3 activation, presumably through the down-regulation of Fas ligand (FasL) and up-regulation of cellular FLIPs (c-FLIPs).


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Purification and stimulation of CD8 T cells

Lymph node cells from 6 to 8-wk-old female C57BL/6 mice (The Jackson Laboratory, Bar Harbor, ME) were bound with microbead-conjugated Abs (Miltenyi Biotec, Auburn, CA) such as anti-CD4, -CD11b, -CD11c, -CD45R, and -MHC class II and then were passed over a midi-MACS column (Miltenyi Biotec). The negatively selected cell population (~95% CD3+ and CD8+) was used in this study. A total of 105 of CD8 T cells were stimulated with plate-coated anti-CD3 (8 µg/ml) plus 20 U/ml human recombinant IL-2 (BD PharMingen, San Diego, CA). Where indicated, either mouse recombinant IL-12 (10 ng/ml; R&D Systems, Minneapolis, MN) or plate-coated anti-CD28 (4 µg/ml) was added to CD8 T cells at the start of cultures.

Abs, reagents, and flow cytometry

Abs to caspase-8 (H-134), caspase-3 (H-277), c-FLIPs (H-202), Bcl-2 (C-2), Bcl-xL (H-5), Bax (P19), cellular inhibitors of apoptosis protein (c-IAP)1 (H-83), c-IAP2 (H-85), and actin for western blot analysis were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The following mAbs (BD PharMingen) were used for immunofluorescent staining: FITC-conjugated anti-CD8, biotinylated anti-Fas (Jo2), biotinylated anti-FasL (MFL3), anti-TNFR-1 (55R-170), anti-TNFR-2 (TR75-32), and biotinylated hamster IgG. For the secondary staining, PerCP-conjugated streptavidin or PE-conjugated anti-hamster IgG was used. Anti-mouse TNF-{alpha} (G281-2626; BD PharMingen) and anti-mouse IFN-{gamma} (XMG1.2; BD PharMingen) were used for neutralization of TNF-{alpha} and IFN-{gamma}, respectively, and the mouse Fas/Fc fusion protein and human IgG were purchased from R&D Systems and Calbiochem (La Jolla, CA), respectively. The caspase inhibitors, such as z-VAD-fmk and z-IETD-fmk, were purchased from Calbiochem and dissolved in DMSO.

Evaluation of apoptosis and Western blot analysis

Apoptosis was detected by dual staining with FITC-conjugated annexin V (BD PharMingen) and propidium iodide (PI) (Sigma-Aldrich, St. Louis, MO) or PI staining of subdiploid DNA. A total of 50 or 100 µg of cell extracts from CD8 T cells were resolved on SDS-PAGE and transferred onto nitrocellulose membranes. After blocking of membrane, the blots were probed with specific Abs, and then visualized with the appropriate HRP-conjugated secondary Abs (Santa Cruz Biotechnology) and an ECL detection system (Pierce, Rockford, IL).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
IL-12 provides survival signals to CD8 T cells

To determine whether IL-12 provides survival signals to CD8 T cells, we examined the apoptosis of CD8 T cells activated with plate-coated anti-CD3 in the presence or absence of recombinant IL-12. The apoptosis was determined either by PI staining of subdiploid DNA or by dual staining with annexin V and PI. As a positive control, CD8 T cells were costimulated with anti-CD28 in addition to anti-CD3, because anti-CD28 was known to provide survival signals to CD8 T cells (8, 9). As expected, CD8 T cells cultured with medium alone survived poorly at 48 h (Table I). Stimulation with anti-CD3 appeared to give survival signals to CD8 T cells within 48 h, but apoptosis rapidly increased at 72 h. This is consistent with a previous report that TCR signaling alone is sufficient for the early activation, proliferation, and survival of CD8 T cells, but it does not give late survival signals (9). In contrast, costimulation with IL-12 or anti-CD28 significantly prevented apoptosis at 72 h, compared with anti-CD3 stimulation alone, suggesting that like anti-CD28, IL-12 provides survival signals to CD8 T cells.


View this table:
[in this window]
[in a new window]
  		Table I. IL-12 provides survival signals to anti-CD3-stimulated CD8+ T cellsa

 
Inhibition of Fas-FasL interaction or caspase activation prevents anti-CD3-induced apoptosis of CD8 T cells

AICD of CD8 T cells was shown to be mediated through TNFR or Fas signaling (10, 11, 12). To determine whether IL-12 prevents CD8 T cell apoptosis through modulating these death-related receptors, we examined the expression levels of Fas, FasL, TNFR-1 (p55), and TNFR-2 (p75) (Fig. 1A). Compared with naive CD8 T cells, the anti-CD3 stimulation alone induced Fas and TNFR-2 expressions, but costimulation with IL-12 or anti-CD28 had no additional effect. The expression of TNFR-1 was not detected in all conditions. Interestingly, costimulation with IL-12 or anti-CD28 was shown to decrease the number of FasL-positive CD8 T cells compared with anti-CD3 stimulation alone. To determine the role of Fas and TNFR signaling in anti-CD3-induced apoptosis of CD8 T cells, we blocked the ligation of Fas or TNFR. The interruption of Fas-FasL interaction with a Fas-Fc protein reduced apoptosis of CD8 T cells stimulated with anti-CD3 alone, but not with anti-CD3 plus IL-12 (Fig. 1B). However, the neutralization of TNF-{alpha} did not affect the apoptosis of CD8 T cells stimulated either with anti-CD3 alone or with anti-CD3 plus IL-12. These results suggest that anti-CD3-induced CD8 T cell apoptosis is mediated by Fas, but not by TNFR, signaling pathway, which is inhibited by IL-12 costimulation. Because a large amount of IFN-{gamma} is produced from activated CD8 T cells by IL-12 (1), we also examined the effect of IFN-{gamma} on the IL-12-mediated CD8 T cell survival by neutralizing IFN-{gamma} (Fig. 1B). Any inhibitory effects were observed in this condition, suggesting that IL-12-induced CD8 T cell survival is independent of IFN-{gamma}. The treatment of either human IgG or rat IgG as a negative control of Fas-Fc or anti-TNF-{alpha} and anti-IFN-{gamma}, respectively, had no effects on apoptosis of CD8 T cells.



View larger version (38K):
[in this window]
[in a new window]
  		FIGURE 1. IL-12 decreases FasL expression, and the blockade of Fas-FasL inhibits the anti-CD3-induced apoptosis of CD8 T cells. A, CD8 T cells were stimulated as indicated for 72 h, and the expression of death receptors in live cells was analyzed. Live CD8 T cells were gated by PI staining or forward light scatter/side light scatter profile. The expression level of each receptor was determined by staining with biotinylated anti-Fas, biotinylated anti-FasL, hamster anti-TNFR1, and hamster anti-TNFR2, followed by streptavidin-PerCP or streptavidin-PE and anti-hamster IgG-PE, respectively (solid line). The dashed lines represent isotype control curves, and the expression level of each receptor in naive CD8 T cells is shown in the shaded curve. B, CD8 T cells were stimulated as indicated for 48 h, and Fas/Fc protein (10 µg/ml), human IgG (10 µg/ml), anti-TNF-{alpha} mAb (25 µg/ml), anti-IFN-{gamma} mAb (25 µg/ml), or anti-rat IgG (25 µg/ml) was added to cultures for an additional 30 h. The results from annexin V-PI dual staining are shown. Representative data of three independent experiments are shown, and each bar indicates the mean value ± SEM.

 
Several cellular molecules are involved in the Fas-mediated apoptosis (13). Upon Fas activation and trimerization, a set of effector proteins is recruited to this receptor, forming a death-inducing signaling complex (DISC). Fas-associated death domain protein, the first protein that binds to Fas, recruits procaspase-8, thereby resulting in the activation of caspase-8. Active caspase-8 initiates a cascade of effector caspase activation, including caspase-3, that eventually leads to the cleavage of cellular death substrates (13). Thus, we next addressed the involvement of caspases in the anti-CD3-induced CD8 T cell apoptosis. As shown in Fig. 2, incubation of z-IETD-fmk, a specific inhibitor of caspase-8, or z-VAD-fmk, a broad spectrum inhibitor of caspases including caspase-3 (14), increased the survival of CD8 T cells stimulated with anti-CD3 alone in a dose-dependent manner. These results suggest that Fas and caspase signaling pathways are involved in the anti-CD3-induced apoptosis of CD8 T cells.



View larger version (21K):
[in this window]
[in a new window]
  		FIGURE 2. Caspase inhibitors prevent the anti-CD3-induced apoptosis of CD8 T cells. CD8 T cells were stimulated as indicated for 48 h, and the caspase inhibitors, z-VAD-fmk and z-IETD-fmk, were added for an additional 30 h. Cell survival was analyzed by annexin V-PI dual staining, and data are shown by relative percentages. Representative data from three independent experiments are shown, and each bar indicates the mean value ± SEM.

 
IL-12 inhibits the activation of caspase-8 and caspase-3 and up-regulates c-FLIPs

To directly answer whether IL-12 negatively regulates caspase activation, we investigated the processing of caspase-8 and caspase-3 in anti-CD3-stimulated CD8 T cells at different time points (Fig. 3). Caspases are initially produced as inactive proenzymes that require processing and heterodimerization for their activity (15). As expected, we could not detect active cleavage products of either caspase-8 or caspase-3 from nonstimulated naive CD8 T cells. A 40-h stimulation of CD8 T cells with anti-CD3 alone generated active caspase-8 (p20), which was further increased at 72 h. In contrast, the active caspase-8 was not detected at 40 h and greatly decreased at 72 h in anti-CD3-stimulated CD8 T cells costimulated with either IL-12 or anti-CD28. The activation of caspase-3 was likely to show a delayed kinetics compared with that of caspase-8, because the active caspase-3 (p20) was not detectable at 40 h in all stimulation conditions. At 72 h, however, the anti-CD3 stimulation alone produced a large amount of active caspase-3 (p20), which was significantly inhibited by the addition of either IL-12 or anti-CD28. Consistently, the costimulation with either IL-12 or anti-CD28 showed higher expression levels of procaspase-8 and procaspase-3 at 72 h than did anti-CD3 stimulation alone. These results suggest that like anti-CD28, costimulation with IL-12 inhibits the activation of caspase-8 and caspase-3, probably through inhibiting the processing of caspases.



View larger version (52K):
[in this window]
[in a new window]
  		FIGURE 3. IL-12 inhibits caspase activation in anti-CD3-induced CD8 T cells. CD8 T cells were stimulated as indicated for 40 or 72 h, and the cleavage of caspase-8 or caspase-3 was determined by Western blot analysis. The results shown here are representatives of three independent experiments.

 
It has been shown that the activation of caspase-8 and caspase-3 is regulated by various cellular anti-apoptotic molecules. Cellular homologues of viral FLICE inhibitory protein, so called c-FLIPs, were shown to prevent Fas-mediated apoptosis by inhibiting caspase-8 activation at the DISC (16, 17). In addition, Bcl-2 family proteins eventually regulate caspase-3 activation through modifying the mitochondrial membrane potential (18), and cellular inhibitors of apoptosis proteins (c-IAPs) are potent inhibitors of caspase-3 (19). Thus, we next addressed whether IL-12 up-regulates the expression of these anti-apoptotic molecules. The anti-CD3 stimulation alone induced both splicing variants of c-FLIPs, c-FLIPlong and c-FLIPshort, at 40 h compared with nonstimulated cells, which was slightly decreased at 72 h (Fig. 4A). This result suggests that the induction of c-FLIPs at the first 40 h of stimulation might be involved in the early survival signal provided by anti-CD3 stimulation alone, but the decreased levels of c-FLIPs by anti-CD3 stimulation alone at 72 h might be correlated with the increase of anti-CD3-induced CD8 T cell apoptosis. Importantly, the induction of c-FLIPs is more prominent in the IL-12-costimulated CD8 T cells at 40 h, which was further enhanced at 72 h, suggesting that the up-regulation of c-FLIPs might play an important role in IL-12-induced CD8 T cell survival. It is possible that c-FLIPs induction might be caused by a lack of Fas engagement because the level of FasL-positive CD8 T cells was decreased by IL-12. However, the increased level of c-FLIPs by IL-12 is also observed in the presence of Fas-Fc protein, which interrupts Fas-FasL interaction (data not shown), suggesting that the up-regulation of c-FLIPs is directly dependent on IL-12. As a positive control, the addition of anti-CD28 also increased c-FLIPs, which agrees well with a previous result in human CD4 T cells (20). However, costimulation with IL-12 or anti-CD28 did not up-regulate c-IAP1/2 molecules, Bcl-2, or Bax, compared with the anti-CD3 stimulation alone (Fig. 4B). It is interesting to note that costimulation with anti-CD28, but not IL-12, slightly increased Bcl-xL. Collectively, these results suggest that IL-12 may inhibit the processing of an initiator caspase, caspase-8, through the up-regulation of c-FLIPs that subsequently suppresses the processing of an effector caspase, caspase-3.



View larger version (34K):
[in this window]
[in a new window]
  		FIGURE 4. IL-12 up-regulates c-FLIPs, but not Bcl-2 family or c-IAP proteins, in anti-CD3-induced CD8 T cells. A, CD8 T cells were stimulated as indicated for 40 or 72 h, and the expression of c-FLIPs and actin was determined by Western blot analysis. B, CD8 T cells were stimulated as indicated for 72 h, and the expression of Bcl-2, Bcl-xL, Bax, c-IAP1, c-IAP2, and actin was determined. The results shown here are representatives of five and three independent experiments for A and B, respectively.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
A primary CD8 T cell response to a newly encountered Ag requires massive proliferation and expansion of naive CD8 T cells, resulting in a large population of effector CD8 T cells. This clonal expansion of Ag-specific CD8 T cells is critical for eliminating pathogens and the development of subsequent immunological memory. However, activation of CD8 T cells through TCR signaling alone results in AICD, which might prevent effective clonal expansion. This ACID can be rescued by a second signal from costimulatory molecules, adhesion molecules, and cytokine receptors (13). In this study, we demonstrate that IL-12 provides survival signals to CD8 T cells through regulation of the Fas-mediated death signaling pathway, including FasL and c-FLIPs expression and caspase activation.

It is well-known that AICD of CD8 T cells is mediated by Fas or the TNFR signaling pathway in different experimental systems (10, 11, 12), and caspase activation might be involved in the CD8 T cell apoptosis as a downstream pathway of these death receptors, although the dependence of caspase cascade in CD8 T cell death has not been extensively studied yet. Based on our data, the anti-CD3-induced CD8 T cell apoptosis is mediated by activation of caspase-8 and caspase-3. In addition, the activation of caspases appeared to be triggered by Fas, but not by the TNFR signaling pathway, because only the interruption of Fas-FasL interaction, but not the neutralization of TNF-{alpha}, reduced the anti-CD3-induced CD8 T cell apoptosis. This is consistent with a report by Zaks et al. (21) showing that the AICD of tumor-reactive CD8 T cells is mediated by Fas interaction and caspase activation. Nevertheless, we did not rule out the possible involvement of other members of the TNFR family, such as TNFR-related apoptosis-mediating protein and TRAIL receptor, in CD8 T cell apoptosis (22, 23). The anti-apoptotic effects of IL-12 on CD8 T cells possibly occur on at least three levels: 1) the down-regulation of FasL+ CD8 T cells, 2) the up-regulation of c-FLIPs, and 3) the down-regulation of active cleavage products of caspase-8 and caspase-3. Therefore, it is likely that costimulation with IL-12 may decrease the Fas-mediated death signals by down-regulating the expression of FasL and the susceptibility against Fas-mediated apoptosis through the up-regulation of c-FLIPs in the anti-CD3-induced CD8 T cells. Meanwhile, costimulation with IL-12 did not up-regulate expression of c-IAPs or Bcl-2 family proteins in CD8 T cells. Interestingly, anti-CD28 costimulation appeared to up-regulate Bcl-xL, but not Bcl-2 and Bax, in CD8 T cells, consistent with a previous report that anti-CD28 increases expression of Bcl-xL in CD4 and CD8 T cells (8, 9). These results suggest that Bcl-xL may play a role in the anti-apoptotic effect of anti-CD28 costimulation in CD8 T cells.

In our study, the up-regulation of both c-FLIPlong and c-FLIPshort by IL-12 costimulation may play an important role in the IL-12-induced CD8 T cell survival. Because c-FLIPlong is structurally homologous to procaspase-8, it can be cleaved at the DISC upon Fas triggering (20). According to this, it can be speculated that the increase of c-FLIPlong expression by IL-12 costimulation in this study might be a consequence of reduced proteolytic processing rather than the result of up-regulation induced by IL-12. However, this increased level of c-FLIPlong was also observed at 40 h of IL-12 costimulation, at which anti-CD3-induced CD8 T cell death was less apparent (data not shown), and thus, less Fas triggering might occur. This suggests that IL-12 actually up-regulates c-FLIPlong as well as c-FLIPshort. To our knowledge, it is the first report to demonstrate that IL-12 up-regulates c-FLIPs that might be involved in the inhibition of caspase activation and subsequent apoptosis of CD8 T cells.

Several reports have shown that the level of c-FLIPs expression is correlated with the sensitivity of Fas-mediated apoptosis in CD4 T cells. The anti-CD28 costimulation reduces AICD of human CD4 T cells through the up-regulation of c-FLIPshort (20), whereas IL-2 enhanced AICD of CD4 T cells via suppression of transcription and expression of c-FLIPlong (24). Despite the importance of c-FLIPs in T cell apoptosis, very little is known about the signaling pathways that control the expression of c-FLIPs. Recent reports showed that mitogen-activated protein kinase kinase 1 induces c-FLIP in activated T cells (25) and that the phosphatidylinositol 3-kinase/Akt pathway is a predominant regulator of c-FLIP expression in tumor cells (26). In this respect, the up-regulation of c-FLIPs by IL-12 in CD8 T cells shown in our findings suggests a possible signaling pathway in c-FLIPs expression, which might be mediated by IL-12R signaling, including a Janus kinase-STAT pathway (1).

Although CD8 T cells play an important role in the host defense system, the mechanism of CD8 T cell apoptosis is not extensively studied compared with that of CD4 T cells. It was suggested that some cytokines may compensate or synergize with costimulatory signals for survival of CD8 T cells. IL-6 and TNF-{alpha} were shown to provide costimulatory pathways for proliferation and survival of CD8 T cells independently of CD28 and IL-2 costimulation (27). Our data also provide evidence that IL-12 can give the survival signals to CD8 T cells in the absence of CD28 costimulation. It can be speculated that the survival signal provided by IL-12 may contribute to the clonal expansion of effector CD8 T cells, which is important for the killing and the clearance of virus-infected cells or tumor cells. Furthermore, this survival signal by IL-12 can also contribute to the generation and maintenance of memory CD8 T cells. Consistently, the immunization of peptide along with IL-12 was shown to prevent the induction of tolerance while supporting the establishment of memory CD8 T cells (28). It is interesting to note that the neutralization of IL-12 showed a marked increase in apoptosis of alloreactive CD8 T cells within the liver grafts from fms-like tyrosine kinase 3 ligand-treated donors, leading to the enhanced graft acceptance (29). These results suggest that the local expression of IL-12 might play a key role in determining the balance between liver transplant tolerance and rejection, presumably caused by the anti-apoptotic effects of IL-12. In summary, our data suggest that IL-12 increases survival of CD8 T cells in TCR-induced cell death, which might provide the important role of IL-12 in peripheral responses of CD8 T cells in autoimmunity, transplantation, and memory generation in vivo.


   Acknowledgments
 
We thank Sang Chun Lee for animal care.


   Footnotes
 
1 This work was supported by a National Research Laboratory Grant from the Korea Institute of Science and Technology Evaluation and Planning (M10204000060) and SRC fund to IRC at the University of Ulsan from KOSEF. Back

2 S.W.L., and Y.P. contributed equally to this work. Back

3 Address correspondence and reprint requests to Dr. Young Chul Sung, Division of Molecular and Life Sciences, Pohang University of Science and Technology, San 31, Hyoja-dong, Nam-ku, Pohang, 790-784, Korea. E-mail address: ycsung{at}postech.ac.kr Back

4 Abbreviations used in this paper: AICD, activation-induced cell death; c-FLIP, cellular FLIP; PI, propidium iodide; FasL, Fas ligand; c-IAPs, cellular inhibitors of apoptosis proteins; DISC, death-inducing signaling complex. Back

Received for publication September 6, 2002. Accepted for publication December 20, 2002.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Trinchieri, G.. 1998. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70:83.[Medline]
  2. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, M. K. Gately. 1996. IL-12-deficient mice are defective in IFN-{gamma} production and type 1 cytokine responses. Immunity 4:471.[Medline]
  3. Gurunathan, S., C. Prussin, D. L. Sacks, R. A. Seder. 1998. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat. Med. 4:1409.[Medline]
  4. Tough, D. F., X. Zhang, J. Sprent. 2001. An IFN-{gamma}-dependent pathway controls stimulation of memory phenotype CD8+ T cell turnover in vivo by IL-12, IL-18, and IFN-{gamma}. J. Immunol. 166:6007.[Abstract/Free Full Text]
  5. Estaquier, J., T. Idziorek, W. Zou, D. Emilie, C. M. Farber, J. M. Bourez, J. C. Ameisen. 1995. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182:1759.[Abstract/Free Full Text]
  6. Marth, T., M. Zeitz, B. R. Ludviksson, W. Strober, B. L. Kelsall. 1999. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells. J. Immunol. 162:7233.[Abstract/Free Full Text]
  7. Palmer, E. M., L. Farrohk-Siar, J. M. van Seventer, G. A. van Seventer. 2001. IL-12 decreases activation-induced cell death in human naive Th cells costimulated by intercellular adhesion molecule-1. I. IL-12 alters caspase processing and inhibits enzyme function. J. Immunol. 167:749.[Abstract/Free Full Text]
  8. Boise, L. H., A. J. Minn, P. J. Noel, C. H. June, M. A. Accavitti, T. Lindsten, C. B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity 3:87.[Medline]
  9. Sperling, A. I., J. A. Auger, B. D. Ehst, I. C. Rulifson, C. B. Thompson, J. A. Bluestone. 1996. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J. Immunol. 157:3909.[Abstract]
  10. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348.[Medline]
  11. The, H. S., A. Seebaran, S. J. Teh. 2000. TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death. J. Immunol. 165:4814.[Abstract/Free Full Text]
  12. Kurts, C., W. R. Heath, H. Kosaka, J. F. A. P. Miller, F. R. Carbone. 1998. The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J. Exp. Med. 188:415.[Abstract/Free Full Text]
  13. Krammer, P. H.. 2000. CD95’s deadly mission in the immune system. Nature 407:789.[Medline]
  14. Vincent, J. K.. 1998. Proteolytic activities that mediated apoptosis. Annu. Rev. Physiol. 60:533.[Medline]
  15. Hengartner, M. O.. 2000. The biochemistry of apoptosis. Nature 407:770.[Medline]
  16. Scaffidi, C., I. Schmitz, P. H. Krammer, M. E. Peter. 1999. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274:1541.[Abstract/Free Full Text]
  17. Irmler, M., K. Hofmann, D. Vaux, J. Tschopp. 1997. Direct physical interaction between the Caenorhabditis elegans "death proteins" CED-3 and CED-4. FEBS Lett. 406:189.[Medline]
  18. Adams, J. M., S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322.[Abstract/Free Full Text]
  19. Roy, N., Q. L. Deveraux, R. Takahashi, G. S. Salvesen, J. C. Reed. 1997. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO. J. 16:6914.[Medline]
  20. Kirchhoff, S., W. W. Muller, M. Li-Weber, P. H. Krammer. 2000. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells. Eur. J. Immunol. 30:2765.[Medline]
  21. Zaks, T. Z., D. B. Chappell, S. A. Rosenberg, N. P. Restifo. 1999. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition. J. Immunol. 162:3273.[Abstract/Free Full Text]
  22. Bodmer, J. L., K. Burns, P. Schneider, K. Hofmann, V. Steiner, M. Thome, T. Bornand, M. Hahne, M. Schroter, K. Becker, et al 1997. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CD95). Immunity 6:79.[Medline]
  23. Schneider, P., M. Thome, K. Burns, J. L. Bodmer, K. Hofmann, T. Kataoka, N. Holler, J. Tschopp. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-{kappa}B. Immunity 7:831.[Medline]
  24. Refaeli, Y., L. Van Parijs, C. A. London, J. Tschopp, A. K. Abbas. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8:615.[Medline]
  25. Yeh, J. H., S. C. Hsu, S. H. Han, M. Z. Lai. 1998. Mitogen-activated protein kinase kinase antagonized Fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression. J. Exp. Med. 188:1795.[Abstract/Free Full Text]
  26. Panka, D. J., T. Mano, T. Suhara, K. Walsh, J. W. Mier. 2001. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J. Biol. Chem. 276:6893.[Abstract/Free Full Text]
  27. Sepulveda, H., A. Cerwenka, T. Morgan, R. W. Dutton. 1999. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. J. Immunol. 163:1133.[Abstract/Free Full Text]
  28. Schmidt, C. S., M. F. Mescher. 1999. Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo. J. Immunol. 163:2561.[Abstract/Free Full Text]
  29. Li, W., L. Lu, Z. Wang, L. Wang, J. J. Fung, A. W. Thomson, S. Qian. 2001. IL-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance. J. Immunol. 166:5619.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
Z. Xiao, K. A. Casey, S. C. Jameson, J. M. Curtsinger, and M. F. Mescher
Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFN
J. Immunol., March 1, 2009; 182(5): 2786 - 2794.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Orbach, J. Rachmilewitz, M. Parnas, J.-H. Huang, M. L. Tykocinski, and M. Dranitzki-Elhalel
CTLA-4 {middle dot} FasL Induces Early Apoptosis of Activated T Cells by Interfering with Anti-Apoptotic Signals
J. Immunol., December 1, 2007; 179(11): 7287 - 7294.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
J.-B. Lee, K.-A Lee, and J. Chang
Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation
Int. Immunol., September 6, 2007; (2007) dxm072v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Friedlein, F. El Hage, I. Vergnon, C. Richon, P. Saulnier, Y. Lecluse, A. Caignard, L. Boumsell, G. Bismuth, S. Chouaib, et al.
Human CD5 Protects Circulating Tumor Antigen-Specific CTL from Tumor-Mediated Activation-Induced Cell Death
J. Immunol., June 1, 2007; 178(11): 6821 - 6827.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Riemann, K. Loser, S. Beissert, M. Fujita, A. Schwarz, T. Schwarz, and S. Grabbe
IL-12 Breaks Dinitrothiocyanobenzene (DNTB)-Mediated Tolerance and Converts the Tolerogen DNTB into an Immunogen
J. Immunol., November 1, 2005; 175(9): 5866 - 5874.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. O. Valenzuela, C. D. Hammerbeck, and M. F. Mescher
Cutting Edge: Bcl-3 Up-Regulation by Signal 3 Cytokine (IL-12) Prolongs Survival of Antigen-Activated CD8 T Cells
J. Immunol., January 15, 2005; 174(2): 600 - 604.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Chang, J.-H. Cho, S.-W. Lee, S.-Y. Choi, S.-J. Ha, and Y.-C. Sung
IL-12 Priming during In Vitro Antigenic Stimulation Changes Properties of CD8 T Cells and Increases Generation of Effector and Memory Cells
J. Immunol., March 1, 2004; 172(5): 2818 - 2826.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. S. Seaman, F. W. Peyerl, S. S. Jackson, M. A. Lifton, D. A. Gorgone, J. E. Schmitz, and N. L. Letvin
Subsets of Memory Cytotoxic T Lymphocytes Elicited by Vaccination Influence the Efficiency of Secondary Expansion In Vivo
J. Virol., January 1, 2004; 78(1): 206 - 215.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S.-J. Ha, D.-J. Kim, K.-H. Baek, Y.-D. Yun, and Y.-C. Sung
IL-23 Induces Stronger Sustained CTL and Th1 Immune Responses Than IL-12 in Hepatitis C Virus Envelope Protein 2 DNA Immunization
J. Immunol., January 1, 2004; 172(1): 525 - 531.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, S. W.
Right arrow Articles by Sung, Y. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S. W.
Right arrow Articles by Sung, Y. C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS